Nasus Pharma
NSRX · NYSE American
$3.24+$0.035 (+1.09%)TodayMarket closed ·
Prev close $3.21
Who owns NSRX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 66.8% of NSRX’s shares.
- Gilboa (Udi)16.4%
- Megiddo (Dalia)16.1%
- Hershman Holdings L.L.C.7.8%
- Balyasny Asset Management LP7.7%
- Next 6 largest institutions18.8%
- All other shareholders33.2%
| Holder | Shares | % of shares |
|---|---|---|
| Gilboa (Udi) | 1.92M | 16.43% |
| Megiddo (Dalia) | 1.89M | 16.13% |
| Hershman Holdings L.L.C. | 909.16K | 7.76% |
| Balyasny Asset Management LP | 898.47K | 7.67% |
| Cable Car Capital, LP | 616.08K | 5.26% |
| Capital Point Ltd | 575.13K | 4.91% |
| Phoenix Solutions Ltd | 429.31K | 3.67% |
| Velan Capital Investment Management LP | 359.39K | 3.07% |
| Hudson Bay Capital Management LP | 134.77K | 1.15% |
| Bleichroeder LP | 89.85K | 0.77% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $31.21K (2 trades) of NSRX on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Teleman Dan Benjamin | Buy | 6.55K | $20.30K |
| Teleman Dan Benjamin | Buy | 2.90K | $10.90K |
Short interest
Settled Sep 30, 2026
- Shares short
- 78.24K
- Days to cover
- 2.87
- % of shares outstanding
- 0.67%
- Average daily volume
- 27.25K
- Change since last report
- −2.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.